Francisco, V.; Tovar, S.; Conde, J.; Pino, J.; Mera, A.; Lago, F.; González-Gay, M.A.; Dieguez, C.; Gualillo, O.
Levels of the Novel Endogenous Antagonist of Ghrelin Receptor, Liver-Enriched Antimicrobial Peptide-2, in Patients with Rheumatoid Arthritis. Nutrients 2020, 12, 1006.
https://doi.org/10.3390/nu12041006
AMA Style
Francisco V, Tovar S, Conde J, Pino J, Mera A, Lago F, González-Gay MA, Dieguez C, Gualillo O.
Levels of the Novel Endogenous Antagonist of Ghrelin Receptor, Liver-Enriched Antimicrobial Peptide-2, in Patients with Rheumatoid Arthritis. Nutrients. 2020; 12(4):1006.
https://doi.org/10.3390/nu12041006
Chicago/Turabian Style
Francisco, Vera, Sulay Tovar, Javier Conde, Jesús Pino, Antonio Mera, Francisca Lago, Miguel Angel González-Gay, Carlos Dieguez, and Oreste Gualillo.
2020. "Levels of the Novel Endogenous Antagonist of Ghrelin Receptor, Liver-Enriched Antimicrobial Peptide-2, in Patients with Rheumatoid Arthritis" Nutrients 12, no. 4: 1006.
https://doi.org/10.3390/nu12041006
APA Style
Francisco, V., Tovar, S., Conde, J., Pino, J., Mera, A., Lago, F., González-Gay, M. A., Dieguez, C., & Gualillo, O.
(2020). Levels of the Novel Endogenous Antagonist of Ghrelin Receptor, Liver-Enriched Antimicrobial Peptide-2, in Patients with Rheumatoid Arthritis. Nutrients, 12(4), 1006.
https://doi.org/10.3390/nu12041006